Stock listing
Lang & Schwarz:A2QLX7 Zevra Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Zevra Therapeutics, Inc. · home listing NASDAQ:ZVRA
Follow Zevra Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ZVRA
$10.10 USD -0.18 (-1.8%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ZVRA
- Day range
- $9.95 – $10.46 USDNov 2, 2026
- Volume
- 636,804 sharesNov 2, 2026
- Market cap
- $599.8M USDAt the close on Nov 2, 2026 · price × 59.38M shares outstanding
- 52-week range
- $8.01 – $15.04 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $10.09M USDMedian day 781,400 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZVRA · Home | $10.10 USD | -0.18 (-1.8%) | 636,804 | $10.29 | $10.46 | $9.95 | $10.28 | Close on Nov 2, 2026 |
| Frankfurt:1GDA | €9.08 EUR | +0.46 (+5.3%) | — | €9.08 | €9.08 | €9.08 | €8.62 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ZVRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.10 | -0.18 | -1.8% | $10.29 | $10.46 | $9.95 | 636,804 | |
| $10.28 | -0.08 | -0.8% | $10.35 | $10.49 | $10.15 | 642,042 | |
| $10.36 | +0.05 | +0.5% | $10.38 | $10.55 | $10.30 | 507,768 | |
| $10.31 | +0.255 | +2.5% | $10.00 | $10.31 | $9.98 | 975,962 | |
| $10.06 | +0.525 | +5.5% | $9.53 | $10.27 | $9.49 | 1,088,794 | |
| $9.53 | -0.28 | -2.9% | $9.84 | $9.89 | $9.46 | 722,191 | |
| $9.81 | -0.52 | -5.0% | $10.25 | $10.25 | $9.76 | 977,700 | |
| $10.33 | -0.03 | -0.3% | $10.36 | $10.61 | $10.24 | 537,200 | |
| $10.36 | -0.11 | -1.1% | $10.48 | $10.50 | $10.32 | 500,600 | |
| $10.47 | +0.31 | +3.1% | $10.31 | $10.56 | $10.22 | 432,200 | |
| $10.16 | +0.22 | +2.2% | $9.94 | $10.20 | $9.84 | 720,200 | |
| $9.94 | -0.33 | -3.2% | $10.29 | $10.29 | $9.885 | 593,900 | |
| $10.27 | +0.04 | +0.4% | $10.40 | $10.60 | $10.22 | 462,400 | |
| $10.23 | -0.16 | -1.5% | $10.10 | $10.60 | $10.08 | 752,600 | |
| $10.39 | -0.93 | -8.2% | $11.33 | $11.33 | $10.24 | 1,090,400 | |
| $11.32 | -0.07 | -0.6% | $11.39 | $11.39 | $11.07 | 508,900 | |
| $11.39 | +0.39 | +3.5% | $10.95 | $11.46 | $10.95 | 730,700 | |
| $11.00 | -0.08 | -0.7% | $11.05 | $11.09 | $10.87 | 486,800 | |
| $11.08 | +0.35 | +3.3% | $10.68 | $11.38 | $10.57 | 936,300 | |
| $10.73 | +0.03 | +0.3% | $10.76 | $10.88 | $10.45 | 614,600 | |
| $10.70 | +0.71 | +7.1% | $10.01 | $10.81 | $10.00 | 1,977,700 | |
| $9.99 | -0.19 | -1.9% | $10.24 | $10.24 | $9.845 | 950,600 | |
| $10.18 | -0.79 | -7.2% | $10.91 | $10.97 | $10.15 | 1,296,000 | |
| $10.97 | -0.37 | -3.3% | $11.37 | $11.38 | $10.94 | 1,818,300 | |
| $11.34 | +0.04 | +0.4% | $11.28 | $11.50 | $11.20 | 1,347,100 | |
| $11.30 | +0.26 | +2.4% | $11.01 | $11.37 | $10.89 | 742,500 | |
| $11.04 | -0.22 | -2.0% | $11.29 | $11.30 | $11.01 | 677,900 | |
| $11.26 | -0.06 | -0.5% | $11.28 | $11.32 | $11.06 | 594,000 | |
| $11.32 | -0.26 | -2.2% | $11.58 | $11.58 | $11.15 | 735,000 | |
| $11.58 | -0.09 | -0.8% | $11.85 | $11.88 | $11.51 | 600,400 | |
| $11.67 | +0.06 | +0.5% | $11.72 | $11.88 | $11.52 | 714,500 | |
| $11.61 | -0.23 | -1.9% | $11.76 | $11.93 | $11.52 | 1,481,700 | |
| $11.84 | +0.04 | +0.3% | $11.96 | $12.29 | $11.79 | 1,591,400 | |
| $11.80 | +0.15 | +1.3% | $11.65 | $11.84 | $11.61 | 795,100 | |
| $11.65 | -0.40 | -3.3% | $12.34 | $12.34 | $11.52 | 916,500 | |
| $12.05 | +0.04 | +0.3% | $12.03 | $12.18 | $11.96 | 614,800 | |
| $12.01 | -0.05 | -0.4% | $12.23 | $12.30 | $11.96 | 582,900 | |
| $12.06 | +0.02 | +0.2% | $11.99 | $12.23 | $11.88 | 675,400 | |
| $12.04 | -0.635 | -5.0% | $12.79 | $12.79 | $12.02 | 923,000 | |
| $12.68 | +0.275 | +2.2% | $12.24 | $12.90 | $12.18 | 1,139,300 | |
| $12.40 | -0.14 | -1.1% | $12.44 | $12.65 | $12.20 | 1,030,000 | |
| $12.54 | +0.24 | +2.0% | $12.42 | $12.55 | $12.26 | 890,500 | |
| $12.30 | +0.24 | +2.0% | $12.07 | $12.39 | $12.04 | 1,347,200 | |
| $12.06 | +0.32 | +2.7% | $11.61 | $12.11 | $11.56 | 1,039,300 | |
| $11.74 | +0.175 | +1.5% | $11.56 | $11.81 | $11.39 | 818,800 | |
| $11.57 | -0.285 | -2.4% | $11.74 | $11.80 | $11.54 | 617,900 | |
| $11.85 | +0.11 | +0.9% | $11.74 | $11.91 | $11.62 | 620,400 | |
| $11.74 | -0.30 | -2.5% | $12.00 | $12.03 | $11.69 | 555,400 | |
| $12.04 | +0.39 | +3.3% | $11.81 | $12.16 | $11.79 | 820,400 | |
| $11.65 | -0.22 | -1.9% | $11.98 | $12.01 | $11.45 | 784,500 | |
| $11.87 | -0.02 | -0.2% | $11.96 | $12.01 | $11.75 | 704,000 | |
| $11.89 | -0.24 | -2.0% | $12.04 | $12.18 | $11.86 | 924,700 | |
| $12.13 | +0.56 | +4.8% | $11.78 | $12.15 | $11.65 | 1,117,900 | |
| $11.57 | +0.04 | +0.3% | $11.48 | $11.64 | $11.32 | 911,500 | |
| $11.53 | +0.21 | +1.9% | $11.27 | $11.58 | $11.18 | 754,300 | |
| $11.32 | +0.14 | +1.3% | $11.01 | $11.36 | $10.81 | 777,800 | |
| $11.18 | -0.26 | -2.3% | $11.47 | $11.60 | $11.14 | 808,000 | |
| $11.44 | -0.04 | -0.3% | $11.46 | $11.51 | $11.35 | 708,500 | |
| $11.48 | 0.00 | 0.0% | $11.48 | $11.48 | $11.48 | 710,500 | |
| $11.48 | -0.08 | -0.7% | $11.47 | $11.53 | $11.22 | 793,900 | |
| $11.56 | -0.32 | -2.7% | $11.91 | $11.97 | $11.35 | 1,262,800 | |
| $11.88 | +1.35 | +12.8% | $11.31 | $12.32 | $11.08 | 2,493,500 | |
| $10.53 | +0.01 | +0.1% | $10.59 | $10.66 | $10.37 | 781,400 | |
| $10.52 | +0.465 | +4.6% | $10.23 | $10.53 | $10.10 | 1,284,500 | |
| $10.06 | +0.545 | +5.7% | $9.51 | $10.08 | $9.49 | 1,753,700 |
- Ticker
- Lang & Schwarz:A2QLX7
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
Latest earnings call · Nov 3, 2026
Zevra Therapeutics (NASDAQ:ZVRA) Q3 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 20 slides
Calls
Replays
Zevra Therapeutics (NASDAQ:ZVRA) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 4:30 PM ET
Watch TranscriptZevra Therapeutics (NASDAQ:ZVRA) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptZevra Therapeutics (NASDAQ:ZVRA) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
Oct 20, 2026
Closed $10.47 (+3.1%) on Oct 20, 2026
Zevra Therapeutics to Present at Upcoming Investor Conferences
Sep 2, 2026
Closed $12.30 (+2.0%) on Sep 2, 2026
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
Aug 25, 2026
Closed $12.04 (+3.3%) on Aug 25, 2026
Zevra Reports Second Quarter 2026 Financial Results and Corporate Update
Aug 5, 2026
Closed $11.88 (+12.8%) on Aug 6, 2026
Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
Aug 4, 2026
Closed $10.52 (+4.6%) on Aug 4, 2026
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)
Aug 3, 2026
Closed $10.06 (+5.7%) on Aug 3, 2026
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
Jul 24, 2026
Closed $9.53 (-23.9%) on Jul 24, 2026
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
Jul 22, 2026
Closed $12.14 (-2.5%) on Jul 22, 2026
Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)
Jun 23, 2026
Closed $13.00 (+2.8%) on Jun 23, 2026
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
Jun 11, 2026
Closed $12.97 (-3.9%) on Jun 11, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 20 slides · October 2026
Q4 2025 Earnings Presentation
Earnings · 20 slides · Mar 9, 2026
INPDA 2025
Conference · 13 slides · September 2025
Q2 2025 Earnings Presentation
Earnings · 35 slides · Aug 12, 2025
Zevra Therapeutics, Inc. on 6ix
- News releases
- 31 in the last 12 months · 218 in all · newest Oct 20, 2026 · oldest 2020
- Calls
- 12 calls with a replay · 12 with a transcript · latest Nov 3, 2026
- Decks
- 61 decks · latest October 2026
Where Zevra Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZVRA · Home listing | NASDAQ | United States | USD |
| gettex:1GDA | gettex | Germany | EUR |
| BOATS:ZVRA | BOATS | United States | USD |
| Tradegate:1GDA | Tradegate | Germany | EUR |
| LS Exchange:A2QLX7 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QLX7 · This page | Lang & Schwarz | Germany | EUR |
| Stuttgart:1GDA | Stuttgart | Germany | EUR |
| Frankfurt:1GDA | Frankfurt | Germany | EUR |
| Dusseldorf:1GDA | Dusseldorf | Germany | EUR |
| Hamburg:1GDA | Hamburg | Germany | EUR |
| Munich:1GDA | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Zevra Therapeutics, Inc.